HomeSVNS • LON
add
Solvonis Therapeutics PLC
Previous close
GBX 0.16
Day range
GBX 0.15 - GBX 0.16
Year range
GBX 0.15 - GBX 0.21
Market cap
3.55M GBP
Avg Volume
7.52M
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
Financials
Income Statement
Revenue
Net income
| (GBP) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 629.00K | 127.08% |
Net income | -629.00K | -108.28% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -600.50K | -130.08% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (GBP) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 940.00K | — |
Total assets | 3.41M | — |
Total liabilities | 138.00K | — |
Total equity | 3.27M | — |
Shares outstanding | 2.30B | — |
Price to book | ∞ | — |
Return on assets | -56.68% | — |
Return on capital | -60.59% | — |
Cash Flow
Net change in cash
| (GBP) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -629.00K | -108.28% |
Cash from operations | -558.00K | -44.19% |
Cash from investing | -300.00K | -1,171.43% |
Cash from financing | 1.77M | — |
Net change in cash | 913.00K | 348.77% |
Free cash flow | -726.12K | — |
About
Founded
2017
Website
Employees
7
